CTNNB1 Circulating Tumour DNA as a Putative Biomarker for Hepatoblastoma

被引：0
|
作者：
Kahana-Edwin, S. [1 ]
Minoche, A. [2 ]
Cain, L. [3 ]
Mccowage, G. [3 ]
Woodfield, S. [4 ]
Vasudevan, S. [5 ]
Kummerfeld, S. [2 ]
Karpelowsky, J. [1 ]
机构：
[1] Childrens Hosp Westmead, Childrens Canc Res Unit, Sydney, NSW, Australia
[2] Garvan Inst Med Res, Kinghorn Ctr Clin Genom, Sydney, NSW, Australia
[3] Childrens Hosp Westmead, Canc Ctr Children, Sydney, NSW, Australia
[4] Baylor Coll Med, Div Pediat Surg & Surg Res, Pediat Surg Oncol Lab, Houston, TX USA
[5] Texas Childrens Hosp, Pediat Surg, Houston, TX USA
来源：
PEDIATRIC BLOOD & CANCER | 2021年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O0002
引用
收藏
页码：S1 / S2
页数：2
相关论文
共 50 条
  • [31] The significance of CTNNB1 mutation in endometrial cancer
    Tuerlinckx, Charlotte
    Vanden Bempt, Isabelle
    Van Rompuy, Anne-Sophie
    Baert, Thais
    Amant, Frederic
    Olbrecht, Siel
    Van De Putte, Toon
    Van Nieuwenhuysen, Els
    Van Gorp, Toon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A48 - A49
  • [32] CTNNB1 Mutation in Aldosterone Producing Adenoma
    Wang, Jian-Jhong
    Peng, Kang-Yung
    Wu, Vin-Cent
    Tseng, Fen-Yu
    Wu, Kwan-Dun
    ENDOCRINOLOGY AND METABOLISM, 2017, 32 (03) : 332 - 338
  • [33] Recurrent CTNNB1 mutations in craniofacial osteomas
    Baumhoer, Daniel
    Berthold, Ruth
    Isfort, Ilka
    Heinst, Lorena
    Ameline, Baptiste
    Grunewald, Inga
    Thieringer, Florian M.
    Rudack, Claudia
    Wardelmann, Eva
    Vieth, Volker
    Sperveslage, Jan
    Trautmann, Marcel
    Hartmann, Wolfgang
    MODERN PATHOLOGY, 2022, 35 (04) : 489 - 494
  • [34] CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma
    Apps, J. R.
    Stache, C.
    Gonzalez-Meljem, J. M.
    Gutteridge, A.
    Chalker, J.
    Jacques, T. S.
    Forshew, T.
    Hoelsken, A.
    Martinez-Barbera, J. P.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2020, 46 (05) : 510 - 514
  • [35] m6A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma (vol 18, 188, 2019)
    Liu, Li
    Wang, Jing
    Sun, Guifeng
    Wu, Qiong
    Ma, Ji
    Zhang, Xin
    Huang, Nan
    Bian, Zhixuan
    Gu, Song
    Xu, Min
    Yin, Minzhi
    Sun, Fenyong
    Pan, Qiuhui
    MOLECULAR CANCER, 2020, 19 (01)
  • [36] Circulating Tumour DNA and Colorectal Cancer: the Next Revolutionary Biomarker?
    Naidoo, Mahendra
    Piercey, Oliver
    Tie, Jeanne
    CURRENT ONCOLOGY REPORTS, 2021, 23 (12)
  • [37] Circulating Tumour DNA and Colorectal Cancer: the Next Revolutionary Biomarker?
    Mahendra Naidoo
    Oliver Piercey
    Jeanne Tie
    Current Oncology Reports, 2021, 23
  • [38] Circulating tumour DNA, a promising biomarker for the management of colorectal cancer
    Khakoo, Shelize
    Georgiou, Alexandros
    Gerlinger, Marco
    Cunningham, David
    Starling, Naureen
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 122 : 72 - 82
  • [39] Circulating Tumour DNA is a Promising Biomarker for Risk Stratification in Chondrosarcoma
    Lyskjaer, I.
    Davies, C.
    Strobl, A. C.
    Hindley, J.
    James, S.
    Lalam, R. K.
    Cross, W.
    Hide, G.
    Rankin, K. S.
    Jeys, L.
    Tirabosco, R.
    Stevenson, J.
    O'Donnell, P.
    Cool, P.
    Flanagan, A. M.
    JOURNAL OF PATHOLOGY, 2022, 256 : S6 - S6
  • [40] CTNNB1 alterations in tissues of patients with colorectal cancer
    Kortan, E. K.
    Shimamoto, F.
    Korpinar, M. A.
    Erdamar, S.
    Tuncel, H.
    FEBS JOURNAL, 2016, 283 : 378 - 378
12345